BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18561666)

  • 1. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac.
    Kry SF; Howell RM; Titt U; Salehpour M; Mohan R; Vassiliev ON
    Med Phys; 2008 May; 35(5):1906-11. PubMed ID: 18561666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced neutron production through use of a flattening-filter-free accelerator.
    Kry SF; Titt U; Pönisch F; Vassiliev ON; Salehpour M; Gillin M; Mohan R
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1260-4. PubMed ID: 17637397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the production of neutrons in laminated barriers for 10 MV medical accelerator rooms.
    Facure A; da Silva AX; da Rosa LA; Cardoso SC; Rezende GF
    Med Phys; 2008 Jul; 35(7):3285-92. PubMed ID: 18697553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo study of photon fields from a flattening filter-free clinical accelerator.
    Vassiliev ON; Titt U; Kry SF; Pönisch F; Gillin MT; Mohan R
    Med Phys; 2006 Apr; 33(4):820-7. PubMed ID: 16696457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery.
    Howell RM; Ferenci MS; Hertel NE; Fullerton GD
    Med Phys; 2005 Mar; 32(3):786-93. PubMed ID: 15839351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the flattening filter on photoneutron production at 10 MV in the Varian TrueBeam linear accelerator.
    Montgomery L; Evans M; Liang L; Maglieri R; Kildea J
    Med Phys; 2018 Oct; 45(10):4711-4719. PubMed ID: 30141186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flattening filter free beams in SBRT and IMRT: dosimetric assessment of peripheral doses.
    Kragl G; Baier F; Lutz S; Albrich D; Dalaryd M; Kroupa B; Wiezorek T; Knöös T; Georg D
    Z Med Phys; 2011 May; 21(2):91-101. PubMed ID: 20888199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment vault shielding for a flattening filter-free medical linear accelerator.
    Kry SF; Howell RM; Polf J; Mohan R; Vassiliev ON
    Phys Med Biol; 2009 Mar; 54(5):1265-73. PubMed ID: 19190359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning and delivery of IMRT using 6 and 18MV photon beams without flattening filter.
    Stathakis S; Esquivel C; Gutierrez A; Buckey CR; Papanikolaou N
    Appl Radiat Isot; 2009 Sep; 67(9):1629-37. PubMed ID: 19369083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose.
    Yonai S; Matsufuji N; Kanai T
    Med Phys; 2009 Oct; 36(10):4830-9. PubMed ID: 19928113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy.
    Kry SF; Howell RM; Salehpour M; Followill DS
    Med Phys; 2009 Apr; 36(4):1244-50. PubMed ID: 19472632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
    Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo study of in-field and out-of-field dose distributions from a linear accelerator operating with and without a flattening-filter.
    Almberg SS; Frengen J; Lindmo T
    Med Phys; 2012 Aug; 39(8):5194-203. PubMed ID: 22894444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo study of backscatter in a flattening filter free clinical accelerator.
    Titt U; Vassiliev ON; Pönisch F; Kry SF; Mohan R
    Med Phys; 2006 Sep; 33(9):3270-3. PubMed ID: 17022221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterization of unflattened photon beams from a 6 MV linear accelerator.
    Cashmore J
    Phys Med Biol; 2008 Apr; 53(7):1933-46. PubMed ID: 18364548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between %dd(10)x and stopping-power ratios for flattening filter free accelerators: a Monte Carlo study.
    Xiong G; Rogers DW
    Med Phys; 2008 May; 35(5):2104-9. PubMed ID: 18561686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
    Vassiliev ON; Kry SF; Kuban DA; Salehpour M; Mohan R; Titt U
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1567-71. PubMed ID: 17544596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.